NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP 50 Pharmas » Wyeth  1    
found files: 5
Wyeth »01/04/2007 [Company watch]
Wyeth considering relocation from China to India

Exasperated by the slow pace of regulatory procedures in China for the approval of new drugs, American pharmaceutical and healthcare giant Wyeth is believed to be exploring the option of relocating its Asian drugs research operations from China to India. Sherry Ku, Wyeth’s senior director in China, has been quoted in the local media as saying on the sidelines of a pharmaceutical conference in Hainan province that, while there was, as of now, no timetable for shifting to India, such a move was possible, even inevitable, if the regulatory environment in mainland China did not improve....   more»


Wyeth »27/04/2007 [Company watch]
Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company

Madison, N.J., April 27, 2007 – Wyeth (NYSE: WYE) today announced that Chief Financial Officer (CFO) and Vice Chairman Kenneth J. Martin has announced plans to leave the Company at the end of June to pursue personal interests. Mr. Martin joined the Company in 1984 and has served as Chief Financial Officer since 2000. Wyeth plans to name a new CFO in advance of Mr. Martin’s departure. "Ken Martin has played key roles at Wyeth for many years and has been an important contributor to our success," says Robert Essner, Chairman and Chief Executive Officer, Wyeth...   more»


Wyeth »10/03/2008 [Company watch]
Wyeth to build world's largest nutritional manufacturing plant in Chin

US Healthcare company Wyeth announced it will invest 2 Billion Yua ($280 Billion Dollars) in the eastern province of Jiangsu to establish a nutritional products manufacturing facility. The new plant which will mainly produce infant milk powder and other nutritional products would be one of the world's largest nutritional product factories when completed. The plant is expected to open in 2010 and output is expected to be sold mainly, for the domestic market....   more»


Wyeth »15/04/2008 [Company watch]
Wyeth complains about slow approval process in China

Wyeth (NYSE: WYE) told Interfax that it would not create an R&D center in China because the SFDA takes too long to approve initial clinical trials (see article). The IND process in the US and Europe involves only a 30-day waiting period, but the same process in China can be nine months or more. On the other hand, even though it will not establish an R&D center in China, Wyeth said it would make several moves to increase its use of China’s R&D expertise....   more»


Wyeth »01/10/2009 [Company watch]
China Requires One Divestiture for Pfizer / Wyeth Merger

The Anti-Monopoly Bureau of China’s Ministry of Commerce ((MOFCOM)) has given its okay to the merger between Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE). However, MOFCOM will require that Pfizer divest its swine mycoplasmal pneumonia vaccine business. Pfizer has been negotiating with the Anti-Monopoly Bureau on the ruling, implying that it will not be surprised by the ruling, even if it may not agree....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.